IP Library Granted Patent US 8,255,034
Granted Patent B2
US 8,255,034 · App. 11/948,915 · Granted Aug 28, 2012

Lyotropic liquid crystal coated analyte monitoring device and methods of use

Assignee: Abbott Diabetes Care Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,255,034
App. No.
11/948,915
Granted
Aug 28, 2012
Kind
B2
Abstract

The present invention is directed to membranes composed liquid crystals having continuous aqueous channels, such as a lyotropic liquid crystal, including a cubic phase lyotropic liquid crystal, and to electrochemical sensors equipped with such membranes. The membranes are useful in limiting the diffusion of an analyte to a working electrode in an electrochemical sensor so that the sensor does not saturate and/or remains linearly responsive over a large range of analyte concentrations. Electrochemical sensors equipped with membranes of the present invention demonstrate considerable sensitivity and stability, and a large signal-to-noise ratio, in a variety of conditions.

Claims (44)

1. An electrochemical analyte sensor for determining the concentration of an analyte, comprising:

a working electrode comprising:

a sensing layer comprising an analyte-responsive enzyme and a redox mediator in contact with the electrode;

a non-crosslinked cubic phase lyotropic liquid crystal membrane disposed on top of the sensing layer, and

a counter or a reference or a counter/reference electrode in electrochemical communication with the working electrode.

2. The electrochemical sensor of claim 1 , wherein the analyte-responsive enzyme is a glucose-responsive enzyme.

3. The electrochemical sensor of claim 2 , wherein the glucose-responsive enzyme is a wired enzyme.

4. The electrochemical sensor of claim 2 , wherein the glucose-responsive enzyme is a glucose-dehydrogenase.

5. The electrochemical sensor of claim 4 , wherein the glucose-dehydrogenase is an FAD-dependent glucose dehydrogenase.

6. The electrochemical sensor of claim 4 , wherein the glucose-dehydrogenase is glucose oxidase.

7. The electrochemical sensor of claim 1 , wherein the redox mediator comprises a ruthenium-containing complex and/or an osmium-containing complex.

8. The electrochemical sensor of claim 1 , wherein the cubic phase lyotropic liquid crystal is substantially non-hydrolyzable in the presence of a lipase.

9. The electrochemical sensor of claim 1 , wherein the cubic phase lyotropic liquid crystal comprises a compound of the formula:

10. The electrochemical sensor of claim 9 , wherein the cubic phase lyotropic liquid crystal comprises Vitamin E acetate.

11. The electrochemical sensor of claim 1 , wherein the sensor is adapted so that at least a portion of the sensor is positionable beneath the skin of a user.

12. The electrochemical sensor of claim 1 , wherein the sensor comprises an anticlotting agent.

13. The electrochemical sensor of claim 12 , wherein the anticlotting agent is heparin.

14. The electrochemical sensor of claim 12 , wherein the cubic phase lyotropic liquid crystal comprises the anticlotting agent.

15. The electrochemical sensor of claim 1 , wherein the cubic phase lyotropic liquid crystal membrane is adapted to limit the flux of glucose or lactate thereacross.

16. The electrochemical sensor of claim 1 , wherein the analyte is glucose.

17. An electrode for use in a biosensor for determining the concentration of an analyte, comprising:

a sensing layer comprising an analyte-responsive enzyme and a redox mediator in contact with the electrode, and

a non-crosslinked cubic phase lyotropic liquid crystal membrane disposed on top of the sensing layer.

18. The electrode of claim 17 , wherein the analyte-responsive enzyme is a glucose-responsive enzyme.

19. The electrode of claim 17 , wherein the redox mediator comprises a complex selected from the group consisting of a ruthenium-containing complex and an osmium-containing complex.

20. The electrode of claim 18 , wherein the glucose-responsive enzyme is a wired enzyme.

21. The electrode of claim 18 , wherein the glucose-responsive enzyme is a glucose-dehydrogenase.

22. The electrode of claim 21 , wherein the glucose-dehydrogenase is an FAD-dependent glucose dehydrogenase.

23. The electrode of claim 21 , wherein the glucose-dehydrogenase is glucose oxidase.

24. The electrode of claim 17 , wherein the redox mediator comprises a ruthenium containing complex and/or an osmium-containing complex.

25. The electrode of claim 17 , wherein the cubic phase lyotropic liquid crystal is substantially non-hydrolyzable in the presence of a lipase.

26. The electrode of claim 17 , wherein the cubic phase lyotropic liquid crystal comprises a compound of the formula:

27. The electrode of claim 26 , wherein the cubic phase lyotropic liquid crystal comprises Vitamin E acetate.

28. The electrode of claim 17 , wherein the cubic phase lyotropic liquid crystal membrane is adapted to limit the flux of glucose or lactate thereacross.

29. The electrode of claim 17 , wherein the cubic phase lyotropic liquid crystal membrane is adapted to limit the flux of glucose or lactate thereacross in vivo.

30. The electrode of claim 17 , wherein the sensing layer comprises an anticlotting agent such as heparin.

31. The electrochemical sensor of claim 1 , wherein the cubic phase lyotropic liquid crystal is non-polymeric.

32. The electrode of claim 17 , wherein the cubic phase lyotropic liquid crystal is non-polymeric.

33. The electrochemical sensor of claim 1 , wherein the cubic phase lyotropic liquid crystal is isotropic.

34. The electrode of claim 17 , wherein the cubic phase lyotropic liquid crystal is isotropic.

35. The electrochemical sensor of claim 1 , wherein the cubic phase lyotropic liquid crystal comprises a link between a polar head and a hydrocarbon tail other than an ester.

36. The electrode of claim 17 , wherein the cubic phase lyotropic liquid crystal comprises a link between a polar head and a hydrocarbon tail other than an ester.

37. The electrochemical sensor of claim 35 , wherein the link between a polar head and hydrocarbon tail is an ether linkage.

38. The electrode of claim 36 , wherein the link between a polar head and hydrocarbon tail is an ether linkage.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2017
From: UNIVERSITY OF TEXAS AT AUSTIN
To: ABBOTT DIABETES CARE INC.
Reel/Frame 044495/0350 →
CONFIRMATORY LICENSE Recorded May 19, 2009
From: TEXAS, UNIVERSITY OF
To: NAVY, SECRETARY OF THE, UNITED STATES OF AMERICA
Reel/Frame 022709/0657 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2008
From: FELDMAN, BENJAMIN
To: ABBOTT DIABETES CARE, INC.
Reel/Frame 020746/0082 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2008
From: ROWINSKI, PAWEL
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 020746/0128 →
Continuity (2)
Provisional Application 60872243 · Nov 30, 2006
Related Publication 20080177164A1 · Jul 24, 2008